NIH-funded research R21 grant

DLK/JNK signaling in distal axons and its role in nerve damage and maintenance

Official title: Physiological and Pathological Roles and Targets of DLK/JNK signaling in distal axons

Funded at Temple Univ of the Commonwealth · NIH-11387968 · Data updated 2026-11-12

This project explores how a specific protein signaling pathway (DLK/JNK) affects nerve fibers after injury and under disease-like conditions, with the aim of finding new ideas to protect or repair neurons.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionTemple Univ of the Commonwealth
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startJune 15, 2026
Project endMay 31, 2028
Funding year2026
Award (this year)$435,875
NIH project number1R21NS149559-01
Project IDNIH-11387968 on NIH RePORTER

Who could benefit from this research

Could help

Not applicable to patient recruitment in this specific R21 grant report; results may inform future studies involving individuals with nerve injury.

Less likely to help

The study itself does not involve patient participation at this stage.

What this research studies

If you or a loved one has nerve injury or related neurodegenerative concerns, this research looks at the signals that travel from damaged nerve endings back to the nerve cell bodies. The scientists will study how DLK/JNK activity changes in healthy versus damaged distal axons and test whether certain phosphorylation events control axon survival and degeneration. They plan targeted experiments to identify key substrates that could become new therapeutic targets to preserve axons or promote repair. The work builds on advanced protein-phosphorylation analysis to uncover mechanisms that could eventually translate into safer, more effective treatments for nervous system injuries.

Why it matters

Potential benefit: Understanding these signals could lead to new strategies to protect axons or slow degeneration after injury.

How similar studies have gone: Previous research has begun mapping DLK/JNK pathways, with emerging evidence that these signals influence axon survival and degeneration; this proposal extends those findings.

Where this research is happening

  • Temple Univ of the Commonwealth
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Thomas, Gareth — Temple Univ of the Commonwealth
  • Study coordinator: Thomas, Gareth

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.